Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Rocket Pharmaceuticals Inc’s stock clocked out at $3.24, down -1.22% from its previous closing price of $3.28. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.71 million shares were traded. RCKT stock price reached its highest trading level at $3.355 during the session, while it also had its lowest trading level at $3.2235.
Ratios:
To gain a deeper understanding of RCKT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4. Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 27 ’25 when Bjork Elisabeth bought 10,000 shares for $3.41 per share. The transaction valued at 34,100 led to the insider holds 40,000 shares of the business.
Militello John sold 699 shares of RCKT for $2,142 on Aug 18 ’25. The insider now owns 56,285 shares after completing the transaction at $3.06 per share. On Aug 19 ’25, another insider, Militello John, who serves as the insider of the company, sold 361 shares for $3.00 each. As a result, the insider received 1,082 and left with 55,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 349608960 and an Enterprise Value of 103316544.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.62, which has changed by -0.8184874 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $22.01, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 5.92%, while the 200-Day Moving Average is calculated to be -56.57%.
Shares Statistics:
It appears that RCKT traded 4.66M shares on average per day over the past three months and 9748790 shares per day over the past ten days. A total of 107.88M shares are outstanding, with a floating share count of 98.88M. Insiders hold about 8.36% of the company’s shares, while institutions hold 84.67% stake in the company. Shares short for RCKT as of 1755216000 were 11725943 with a Short Ratio of 2.51, compared to 1752537600 on 12898169. Therefore, it implies a Short% of Shares Outstanding of 11725943 and a Short% of Float of 21.16.
Earnings Estimates
The current rating of Rocket Pharmaceuticals Inc (RCKT) reflects the combined expertise of 14.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$1.19, with 13.0 analysts recommending between $0.69 and -$2.13.
